NCT04323202 2025-10-24
Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N
Case Comprehensive Cancer Center
Phase 1 Completed
Case Comprehensive Cancer Center
Medical University of South Carolina
Dartmouth-Hitchcock Medical Center
H. Lee Moffitt Cancer Center and Research Institute